Predicate |
Object |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-94 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-565 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2863 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 |
filingDate |
2012-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2017-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2017-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CN-103619881-B |
titleOfInvention |
New EGFR associated proteins |
abstract |
Describe the antigen-binding proteins interacted with EGF-R ELISA (EGFR), such as antibody.Also describe by the antigen-binding proteins for EGFR for applying pharmacy effective dose come treating cancer and the method for other diseases. |
priorityDate |
2011-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |